Close Menu

NEW YORK – A new European consortium led by Swiss molecular diagnostics firm Novigenix has been awarded up to €1 million ($1.1 million) from Eurostars, which is funded by European governments and the European Union, to develop a blood-based multi-omics colorectal cancer (CRC) assay.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.